title: Effect of switching xanthine oxidoreductase inhibitor from febuxostat to topiroxostat on urinary protein excretion.
authors.affiliation: Dialysis Center, Fukushima Medical University, Fukushima, Japan. terawaki@fmu.ac.jp.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Terawaki
authors.affiliation: Hoshi General Hospital Foundation, Fukushima, Japan.
authors.forename: Hokuto
authors.initials: H
authors.lastname: Hoshi
authors.affiliation: Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan.
authors.forename: Junichiro James
authors.initials: JJ
authors.lastname: Kazama
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D057915:Drug Substitution; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D000069465:Febuxostat / Q000627:therapeutic use*; D005260:Female; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D011507:Proteinuria / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology*; D011725:Pyridines / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D016896:Treatment Outcome; D014968:Xanthine Dehydrogenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D006074:Gout Suppressants; D009570:Nitriles; D011725:Pyridines; C504882:FYX-051; D000069465:Febuxostat; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase